# A Study to Investigate the Efficacy and Safety of Roxadustat (FG-4592) for Treating Anemia in Participants With Myelodysplastic Syndromes (MDS)

> **NCT07722988** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Kyntra Bio** · enrollment: 201 (estimated)

## Conditions studied

- Myelodysplastic Syndromes

## Interventions

- **DRUG:** Roxadustat
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07722988
- **Lead sponsor:** Kyntra Bio
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2027-04
- **Primary completion:** 2030-09
- **Final completion:** 2032-12
- **Target enrollment:** 201 (ESTIMATED)
- **Last updated:** 2026-07-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07722988

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07722988, "A Study to Investigate the Efficacy and Safety of Roxadustat (FG-4592) for Treating Anemia in Participants With Myelodysplastic Syndromes (MDS)". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07722988. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*